We are live on ! Find out more
NNVC icon

NanoViricides

26 hedge funds and large institutions have $5.7M invested in NanoViricides in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

53% more capital invested

Capital invested by funds: $3.74M → $5.7M (+$1.96M)

0% more funds holding

Funds holding: 2626 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.39% less ownership

Funds ownership: 8.79%8.4% (-0.39%)

Holders
26
Holders Change
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
-$122K -21,236 Closed
HIS
27
Harvest Investment Services
Illinois
-$109K -19,135 Closed
WS
28
Wedbush Securities
California
-$59K -10,315 Closed
US Bancorp
29
US Bancorp
Minnesota
+$264 +38 +760%

NNVC Hedge Fund Activity: Q2 2020 in Review

26 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2020, worth a combined $5.7M — up 53% from $3.74M a quarter earlier.

Fund positioning in NNVC was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $1.85M. The largest seller was Goldman Sachs, cutting an estimated $1.62M.

  • 26 institutional investors held NanoViricides (NNVC) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $5.7M of NanoViricides stock for Q2 2020, up 53% quarter-over-quarter.
  • 4 funds opened new NanoViricides positions in Q2 2020 and 4 closed out, a net change of 0 holders.
  • The largest NanoViricides buyer in Q2 2020 was BlackRock, an estimated $1.85M added.
  • The largest NanoViricides seller in Q2 2020 was Goldman Sachs, an estimated $1.62M sold.

Based on aggregated 13F filings for Q2 2020.